Publicaciones en colaboración con investigadores/as de University of Montpellier (22)

2024

  1. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles, Vol. 13, Núm. 2

2022

  1. Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis

    Neurology, Vol. 99, Núm. 17, pp. E1926-E1944

  2. Household income, fetal size and birth weight: an analysis of eight populations

    Journal of Epidemiology and Community Health, Vol. 76, Núm. 7, pp. 629-636

  3. Inflammation biomarkers in suicide attempts and their relation to abuse, global functioning and cognition

    World Journal of Biological Psychiatry, Vol. 23, Núm. 4, pp. 307-317

  4. New insights into the genetic etiology of Alzheimer's disease and related dementias

    Nature genetics, Vol. 54, Núm. 4, pp. 412-436

2021

  1. 2021 Taxonomic update of phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales

    Archives of Virology, Vol. 166, Núm. 12, pp. 3513-3566

  2. Correction to: 2021 Taxonomic update of phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales (Archives of Virology, (2021), 166, 12, (3513-3566), 10.1007/s00705-021-05143-6)

    Archives of Virology

  3. Determinants of therapeutic lag in multiple sclerosis

    Multiple Sclerosis Journal, Vol. 27, Núm. 12, pp. 1838-1851

  4. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  5. Neddylation inhibition ameliorates steatosis in NAFLD by boosting hepatic fatty acid oxidation via the DEPTOR-mTOR axis

    Molecular Metabolism, Vol. 53

2020

  1. 2020 taxonomic update for phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales

    Archives of Virology, Vol. 165, Núm. 12, pp. 3023-3072

2019

  1. Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study

    Alzheimer's and Dementia, Vol. 15, Núm. 6, pp. 742-753

2018

  1. European Prevention of Alzheimer's Dementia Registry: Recruitment and prescreening approach for a longitudinal cohort and prevention trials

    Alzheimer's and Dementia, Vol. 14, Núm. 6, pp. 837-842

  2. Interim 2017/18 influenza seasonal vaccine effectiveness: Combined results from five European studies

    Eurosurveillance, Vol. 23, Núm. 9

2017

  1. Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

    Journal of Nutrition, Health and Aging, Vol. 21, Núm. 1, pp. 92-104

2015

  1. Operational definition of Active and Healthy Ageing (AHA): A conceptual framework

    Journal of Nutrition, Health and Aging, Vol. 19, Núm. 9, pp. 955-960

  2. Operative definition of active and healthy ageing (AHA): Meeting report. Montpellier October 20-21, 2014

    European Geriatric Medicine, Vol. 6, Núm. 2, pp. 196-200

2013

  1. Anti-tumour immunotherapy with Vγ9Vδ2 T lymphocytes: From the bench to the bedside

    British Journal of Haematology, Vol. 160, Núm. 2, pp. 123-132

2011

  1. γδT-cell killing of primary follicular lymphoma cells is dramatically potentiated by GA101, a type II glycoengineered anti-CD20 monoclonal antibody

    Haematologica, Vol. 96, Núm. 3, pp. 400-407

2010

  1. γδ T lymphocytes count is normal and expandable in peripheral blood of patients with follicular lymphoma, whereas it is decreased in tumor lymph nodes compared with inflammatory lymph nodes

    Journal of Immunology, Vol. 184, Núm. 1, pp. 134-140